CD274 and neoplasm: The mechanism of action is to stimulate the immune system against tumor cells by blocking specific receptors, including cytotoxic T-lymphocyte-4 (CTLA-4) and programmed death-1 (PD-1), or its ligand (PD-L1) [3].